Skip to main content

Cervical Cancer

  • Chapter
  • First Online:

Abstract

Since its inception in 1948, MD Anderson Cancer Center has been at the forefront of innovative cervical cancer treatment. In the 1940s, cervical cancer was still a very important public health problem in the United States. Although cytologic screening and treatment of preinvasive disease subsequently led to a dramatic reduction in the incidence of invasive cervical cancer in the United States, this disease continues to affect about 11,000 women per year. In 2009, an estimated 4,070 women died of cervical cancer in the United States. Cervical cancer disproportionately affects medically underserved women in the United States and is still a leading cause of cancer death for women in many underdeveloped countries. During the past 60 years, innovations in treatment have substantially improved outcome and quality of life for many patients with this disease.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Young Jr JL, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, editors. SEER summary staging manual – 2000: codes and coding instructions. NIH Pub. No. 01-4969. Bethesda: National Cancer Institute; 2001.

    Google Scholar 

  2. Suit HD, Moore EB, Fletcher GH, et al. Modification of Fletcher ovoid system for afterloading, using standard-sized radium tubes (milligram and microgram). Radiology. 1963;81:126–31.

    PubMed  CAS  Google Scholar 

  3. Fletcher GH, Rutledge FN, Chau PM. Policies of treatment in cancer of the cervix uteri. Am J Roentgenol Radium Ther Nucl Med. 1962;87:6–21.

    PubMed  CAS  Google Scholar 

  4. Fletcher GH. Cancer of the uterine cervix. Janeway Lecture, 1970. Am J Roentgenol Radium Ther Nucl Med. 1971;3:225–42.

    Google Scholar 

  5. Eifel PJ, Levenback C, Wharton JT, et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1995;32:1289–300.

    Article  PubMed  CAS  Google Scholar 

  6. Eifel PJ, Morris M, Wharton JT, et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1994;29:9–16.

    Article  PubMed  CAS  Google Scholar 

  7. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90–01. J Clin Oncol. 2004;22:872–80.

    Article  PubMed  Google Scholar 

  8. Ramirez PT, Schmeler KM, Malpica A, et al. Safety and feasibility of robotic radical trachelectomy in patients with early-stage cervical cancer. Gynecol Oncol. 2010;116:512–5.

    Article  PubMed  Google Scholar 

  9. Ramirez PT, Schmeler KM, Soliman PT, et al. Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol Oncol. 2008;110:S25–8.

    Article  PubMed  Google Scholar 

  10. Levenback C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002;20:688–93.

    Article  PubMed  Google Scholar 

  11. Piver S, Wallace S, Castro JR. The accuracy of lymphangiography in carcinoma of the uterine cervix. Am J Roentgenol. 1971;111:97–101.

    Google Scholar 

  12. Wharton JT, Jones 3rd HW, Day Jr TG, et al. Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix. Obstet Gynecol. 1977;49:333–8.

    PubMed  CAS  Google Scholar 

  13. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43:763–75.

    Article  PubMed  CAS  Google Scholar 

  14. Ijaz T, Eifel PJ, Burke T, et al. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 1998;70:241–6.

    Article  PubMed  CAS  Google Scholar 

  15. Rutledge FN, Burns Jr BC. Pelvic exenteration. Am J Obstet Gynecol. 1965;91:692–708.

    PubMed  CAS  Google Scholar 

  16. Eifel PJ. Problems with the clinical staging of carcinoma of the cervix. Semin Radiat Oncol. 1994;4:1–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia J. Eifel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Eifel, P.J., Levenback, C. (2013). Cervical Cancer. In: Rodriguez, M., Walters, R., Burke, T. (eds) 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5197-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5197-6_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-5196-9

  • Online ISBN: 978-1-4614-5197-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics